16,16-diethoxy-15,15-dimethyl-2-azoniatetracyclo[6.6.2.02,7.09,14]hexadeca-2(7),3,5,9(14),10,12-hexaene chloride

ID: ALA52124

Chembl Id: CHEMBL52124

PubChem CID: 9928805

Max Phase: Preclinical

Molecular Formula: C21H26ClNO2

Molecular Weight: 324.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC1(OCC)C2c3ccccc3C([n+]3ccccc32)C1(C)C.[Cl-]

Standard InChI:  InChI=1S/C21H26NO2.ClH/c1-5-23-21(24-6-2)18-15-11-7-8-12-16(15)19(20(21,3)4)22-14-10-9-13-17(18)22;/h7-14,18-19H,5-6H2,1-4H3;1H/q+1;/p-1

Standard InChI Key:  RAEOHAGJDWNAEH-UHFFFAOYSA-M

Associated Targets(non-human)

Grin1 Glutamate NMDA receptor (6467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprm1 Opioid receptor (338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1d Alpha-1 adrenergic receptor (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2b Alpha-2 adrenergic receptor (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adrb1 Beta-adrenergic receptor (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm5 Muscarinic acetylcholine receptor (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hrh1 Histamine H1 receptor (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine D1 receptor (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (252 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 324.44Molecular Weight (Monoisotopic): 324.1958AlogP: 3.82#Rotatable Bonds: 4
Polar Surface Area: 22.34Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 0.12CX LogD: 0.12
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: 0.27

References

1. Kumar V, Carabateas PM, Dority JA, Earley WG, Mallamo JP, Subramanyam C, Aimone LD, Ault B, DeHaven Hudkins DL, Miller MS..  (1995)  Novel NMDA antagonists: replacement of the pyridinium ring of 6,11-ethanobenzo[b]quinolizinium cations with heteroisoquinolinium cations.,  38  (10): [PMID:7752207] [10.1021/jm00010a028]
2. Subramanyam C, Mallamo JP, Dority JA, Earley WG, Kumar V, Aimone LD, Ault B, Miller MS, Luttinger DA, DeHaven-Hudkins DL..  (1995)  Discovery of 6,11-ethano-12,12-diaryl-6,11-dihydrobenzo[b]quinolizinium cations, a novel class of N-methyl-D-aspartate antagonists.,  38  (1): [PMID:7837234] [10.1021/jm00001a006]
3. Mallamo JP, Earley WG, Kumar V, Subramanyam C, Dority JA, Miller MS, DeHaven-Hudkins DL, Ault B, Herrmann JL, Dung JS..  (1994)  Identification, synthesis, and characterization of a unique class of N-methyl-D-aspartate antagonists. The 6,11-ethanobenzo[b]quinolizinium cation.,  37  (26): [PMID:7528282] [10.1021/jm00052a003]
4. Mallamo JP, Earley WG, Kumar V, Subramanyam C, Dority JA, Miller MS, DeHaven-Hudkins DL, Ault B, Herrmann JL, Dung JS..  (1994)  Identification, synthesis, and characterization of a unique class of N-methyl-D-aspartate antagonists. The 6,11-ethanobenzo[b]quinolizinium cation.,  37  (26): [PMID:7528282] [10.1021/jm00052a003]
5. Mallamo JP, Earley WG, Kumar V, Subramanyam C, Dority JA, Miller MS, DeHaven-Hudkins DL, Ault B, Herrmann JL, Dung JS..  (1994)  Identification, synthesis, and characterization of a unique class of N-methyl-D-aspartate antagonists. The 6,11-ethanobenzo[b]quinolizinium cation.,  37  (26): [PMID:7528282] [10.1021/jm00052a003]

Source